Literature DB >> 25378534

Investigating the interaction between the neonatal Fc receptor and monoclonal antibody variants by hydrogen/deuterium exchange mass spectrometry.

Pernille Foged Jensen1, Vincent Larraillet2, Tilman Schlothauer2, Hubert Kettenberger2, Maximiliane Hilger3, Kasper D Rand4.   

Abstract

The recycling of immunoglobulins by the neonatal Fc receptor (FcRn) is of crucial importance in the maintenance of antibody levels in plasma and is responsible for the long half-lives of endogenous and recombinant monoclonal antibodies. From a therapeutic point of view there is great interest in understanding and modulating the IgG-FcRn interaction to optimize antibody pharmacokinetics and ultimately improve efficacy and safety. Here we studied the interaction between a full-length human IgG(1) and human FcRn via hydrogen/deuterium exchange mass spectrometry and targeted electron transfer dissociation to map sites perturbed by binding on both partners of the IgG-FcRn complex. Several regions in the antibody Fc region and the FcRn were protected from exchange upon complex formation, in good agreement with previous crystallographic studies of FcRn in complex with the Fc fragment. Interestingly, we found that several regions in the IgG Fab region also showed reduced deuterium uptake. Our findings indicate the presence of hitherto unknown FcRn interaction sites in the Fab region or a possible conformational link between the IgG Fc and Fab regions upon FcRn binding. Further, we investigated the role of IgG glycosylation in the conformational response of the IgG-FcRn interaction. Removal of antibody glycans increased the flexibility of the FcRn binding site in the Fc region. Consequently, FcRn binding did not induce a similar conformational stabilization of deglycosylated IgG as observed for the wild-type glycosylated IgG. Our results provide new molecular insight into the IgG-FcRn interaction and illustrate the capability of hydrogen/deuterium exchange mass spectrometry to advance structural proteomics by providing detailed information on the conformation and dynamics of large protein complexes in solution.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25378534      PMCID: PMC4288250          DOI: 10.1074/mcp.M114.042044

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  59 in total

1.  Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding.

Authors:  W L Martin; A P West; L Gan; P J Bjorkman
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

2.  Post-translational modifications differentially affect IgG1 conformation and receptor binding.

Authors:  Damian Houde; Yucai Peng; Steven A Berkowitz; John R Engen
Journal:  Mol Cell Proteomics       Date:  2010-01-26       Impact factor: 5.911

3.  Characterization of IgG1 Conformation and Conformational Dynamics by Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Damian Houde; Joseph Arndt; Wayne Domeier; Steven Berkowitz; John R Engen
Journal:  Anal Chem       Date:  2009-07-15       Impact factor: 6.986

4.  Identification of critical IgG binding epitopes on the neonatal Fc receptor.

Authors:  D E Vaughn; C M Milburn; D M Penny; W L Martin; J L Johnson; P J Bjorkman
Journal:  J Mol Biol       Date:  1997-12-12       Impact factor: 5.469

Review 5.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Authors:  P Mark Hogarth; Geoffrey A Pietersz
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

6.  Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.

Authors:  W P Burmeister; L N Gastinel; N E Simister; M L Blum; P J Bjorkman
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

7.  Enhanced antibody half-life improves in vivo activity.

Authors:  Jonathan Zalevsky; Aaron K Chamberlain; Holly M Horton; Sher Karki; Irene W L Leung; Thomas J Sproule; Greg A Lazar; Derry C Roopenian; John R Desjarlais
Journal:  Nat Biotechnol       Date:  2010-01-17       Impact factor: 54.908

8.  Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.

Authors:  Takuo Suzuki; Akiko Ishii-Watabe; Minoru Tada; Tetsu Kobayashi; Toshie Kanayasu-Toyoda; Toru Kawanishi; Teruhide Yamaguchi
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

9.  Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn.

Authors:  Hai Pan; Kenneth Chen; Liping Chu; Francis Kinderman; Izydor Apostol; Gang Huang
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

10.  Ion mobility adds an additional dimension to mass spectrometric analysis of solution-phase hydrogen/deuterium exchange.

Authors:  Roxana E Iacob; James P Murphy; John R Engen
Journal:  Rapid Commun Mass Spectrom       Date:  2008-09       Impact factor: 2.586

View more
  28 in total

1.  Investigating the Role of Artemin Glycosylation.

Authors:  Qiu Danwen; Christian Code; Chao Quan; Bang-Jin Gong; Joseph Arndt; Blake Pepinsky; Kasper D Rand; Damian Houde
Journal:  Pharm Res       Date:  2016-02-23       Impact factor: 4.200

2.  A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life.

Authors:  Pernille Foged Jensen; Angela Schoch; Vincent Larraillet; Maximiliane Hilger; Tilman Schlothauer; Thomas Emrich; Kasper Dyrberg Rand
Journal:  Mol Cell Proteomics       Date:  2017-01-06       Impact factor: 5.911

3.  Conformational Destabilization of Immunoglobulin G Increases the Low pH Binding Affinity with the Neonatal Fc Receptor.

Authors:  Benjamin T Walters; Pernille F Jensen; Vincent Larraillet; Kevin Lin; Thomas Patapoff; Tilman Schlothauer; Kasper D Rand; Jennifer Zhang
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

Review 4.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.

Authors:  Jonathan T Sockolosky; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2015-02-19       Impact factor: 15.470

5.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

Review 6.  Targeting FcRn for the modulation of antibody dynamics.

Authors:  E Sally Ward; Siva Charan Devanaboyina; Raimund J Ober
Journal:  Mol Immunol       Date:  2015-03-09       Impact factor: 4.407

7.  Human Stress-inducible Hsp70 Has a High Propensity to Form ATP-dependent Antiparallel Dimers That Are Differentially Regulated by Cochaperone Binding.

Authors:  Filip Trcka; Michal Durech; Pavla Vankova; Josef Chmelik; Veronika Martinkova; Jiri Hausner; Alan Kadek; Julien Marcoux; Tomas Klumpler; Borivoj Vojtesek; Petr Muller; Petr Man
Journal:  Mol Cell Proteomics       Date:  2018-11-20       Impact factor: 5.911

Review 8.  Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Jake Pawlowski; Guanbo Wang
Journal:  J Pharm Biomed Anal       Date:  2020-02-12       Impact factor: 3.935

9.  Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.

Authors:  Jayant Arora; Yue Hu; Reza Esfandiary; Hasige A Sathish; Steven M Bishop; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; David D Weis
Journal:  MAbs       Date:  2016-08-25       Impact factor: 5.857

10.  Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.

Authors:  Chiara Orlandi; Daniel Deredge; Krishanu Ray; Neelakshi Gohain; William Tolbert; Anthony L DeVico; Patrick Wintrode; Marzena Pazgier; George K Lewis
Journal:  Structure       Date:  2020-03-24       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.